[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].

Article

[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].

Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 1994

Iwabuchi S, Osada T, Takatori M, Yoshida H

Abstract excerpt

Possible effects of IFN and SNMC combination therapy for active liver cirrhosis were described. 28 patients with active liver cirrhosis were treated with natural IFN alpha 3-6 MU TIW for 3-17 months (mean, 8 +/- 6). 8 of 28 patients received combination therapy of SNMC (40 ml iv, TIW). 8 (29%) of...

Topics

Biomarkers
Cysteine
Drug Combinations
Drug Therapy, Combination
Female
Genotype
Glycine
Hepacivirus
Hepatitis C
Humans
Interferons
Liver Cirrhosis
Middle Aged
Oleanolic Acid
RNA, Viral

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.